Taiwan
6 Vaccines Approved for Use in Taiwan
Protein Subunit
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
Approval Source: taiwannews.com.tw
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: cdc.gov.tw
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
Approval Source: taiwannews.com.tw
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: taipeitimes.com
7 in Clinical Trials in Taiwan
Protein Subunit
COVAXX
UB-612
7 trials in 2 countries
Protein Subunit
Medigen
MVC-COV1901
Approved in 4 countries
15 trials in 4 countries
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Protein Subunit
Adimmune Corporation
AdimrSC-2f
3 trials in 2 countries
Protein Subunit
Medigen